Strata Critical Medical, Inc. logo SRTA - Strata Critical Medical, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $7.25 DETAILS
HIGH: $7.25
LOW: $7.25
MEDIAN: $7.25
CONSENSUS: $7.25
UPSIDE: 35.14%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q3 2021 Q4 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Revenue
Revenue 67.4 66.8 49.3 70.8 54.3 54.4 74.9 67.9 51.5 47.5 71.4 61.0 45.3 38.1 45.7 35.6 26.6 20.3 24.6 13.0 0 8.0 8.3 3.4 0 5.2 0
Cost of Revenue 53.3 55.1 37.7 53.1 42.3 41.8 55.0 51.6 41.4 38.5 55.9 50.6 38.1 33.2 36.5 30.5 23.7 15.8 20.6 9.9 0 6.4 6.7 2.8 0 5.8 0.0
Gross Profit 14.1 11.7 11.6 17.7 12.0 12.6 19.8 16.4 10.1 9.0 15.6 10.4 7.2 5.0 9.3 5.1 2.9 4.5 4.0 3.0 0 1.6 1.6 0.6 0 (0.5) (0.0)
Operating Expenses
R&D Expenses 0 0 0.5 0.9 0.8 0.7 0.8 1.0 0.7 1.0 1.1 1.4 1.1 1.6 2.0 1.1 0.8 1.0 0.6 0.2 0 0.2 0.2 0.2 0 0.2 0
SG&A Expenses 15.6 16.8 16.8 21.8 18.7 20.2 22.6 27.5 19.3 43.7 22.0 21.1 18.9 23.0 17.7 13.8 15.8 13.3 13.9 10.6 0.2 3.8 2.2 1.9 0.1 4.0 0.0
Other Expenses 1.5 1.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0
Operating Expenses 17.1 18.1 17.2 22.7 19.6 21.0 23.4 28.5 20.0 44.6 23.0 22.6 20.0 24.7 19.7 14.8 16.6 14.2 14.5 10.8 0.2 4.0 2.3 2.1 0.1 4.3 0.0
Operating Income
Operating Income (3.0) (6.4) (5.6) (5.0) (7.6) (8.4) (3.5) (12.1) (9.9) (35.6) (7.4) (12.2) (12.8) (19.7) (10.4) (9.7) (13.7) (9.7) (10.5) (7.8) (0.2) (2.4) (0.7) (1.5) (0.1) (4.8) 0.1
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.1 0 0 0 (0.1) 0 0 0 0 0
Interest Income 0.5 0.6 1.1 1.2 1.3 1.6 1.8 1.8 2.1 2.3 2.1 2.1 2.0 1.5 1.2 0.5 0.3 0.3 0.3 0 0.0 0 0 0 0.1 0.1 0
Profitability
EBITDA 0.1 (3.4) (8.0) (1.9) (1.8) (8.4) (0.8) (9.7) (2.7) (33.2) 2.3 (10.8) (9.2) (16.2) (7.8) 9.6 (9.6) (12.5) 1.4 (24.3) (0.2) (2.2) (0.6) (1.3) 0.7 (4.7) (81.9)
EBIT (3.0) (6.4) (9.7) (3.7) (3.5) (9.9) (2.1) (11.3) (4.3) (35.0) 0.4 (12.6) (10.4) (16.2) (9.2) 8.4 (10.7) (12.7) 0.7 (24.3) (0.2) (2.4) (0.7) (1.5) (0.1) (4.8) 0.1
Income Before Tax 2.4 (5.4) (9.7) (3.7) (3.5) (9.9) (2.1) (11.3) (4.3) (35.0) 0.4 (12.6) (10.4) (16.2) (9.2) 8.4 (11.0) (12.8) 0.7 (24.3) (1.1) (2.4) (0.7) (1.3) 0.7 (4.7) 0.1
Income Tax Expense 0 0 0 0.0 (0.0) (0.1) (0.1) 0.1 (0.1) (1.0) 0.1 (0.4) (0.2) (0.8) 0.1 0.3 (0.3) (3.6) (0.1) 0 0 0 0 0 0.2 0 0.0
Net Income 2.2 (8.8) 57.4 (3.7) (3.5) (9.8) (2.0) (11.3) (4.2) (33.9) 0.3 (12.2) (10.2) (15.4) (9.2) 8.1 (10.7) (9.2) 0.8 (24.3) (1.1) (2.4) (0.7) (1.3) 0.6 (4.7) 0.1
Per Share Data
EPS (Basic) 0.03 -0.11 -0.04 -0.05 -0.04 -0.12 -0.03 -0.15 -0.06 -0.45 0.00 -0.17 -0.14 -0.22 -0.13 0.12 -0.15 -0.13 0.01 -0.47 -0.06 -0.06 -0.01 -0.00 0.07 0.02
EPS (Diluted) 0.03 -0.11 -0.04 -0.05 -0.04 -0.12 -0.03 -0.15 -0.06 -0.45 0.00 -0.17 -0.14 -0.22 -0.13 0.12 -0.15 -0.13 0.01 -0.33 -0.06 -0.06 -0.01 -0.00 0.07 0.02
Shares Outstanding 85.3 82.5 82.5 81.3 79.9 79.4 78.0 78.0 75.8 74.7 74.1 72.0 72.0 71.7 71.1 71.1 68.8 69.0 69.8 51.6 69.2 40.9 8.2 8.2 8.2 8.2 6.5
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q3 2021 Q4 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Current Assets
Cash & Cash Equivalents 58.7 31.0 22.8 58.8 34.8 18.4 20.0 26.3 36.8 27.9 36.8 37.3 41.7 41.3 51.8 186.6 2.5 7.0 2.6 30.0 10.2 0.8 12.2 1.0 1.1 1.3 1.8
Short-Term Investments 0.1 30.3 53.2 54.7 85.2 108.8 116.3 115.6 114.2 138.3 136.4 132.3 135.2 150.7 150.4 69.6 266.6 297.2 279.4 303.2 0 0.3 0 0 0 276.3 0
Net Receivables 39.6 40.0 37.5 28.2 22.1 21.6 24.5 27.7 23.6 21.0 21.0 22.5 16.5 10.9 11.3 9.7 6.0 3.8 5.5 1.7 1.5 0 1.1 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0.5 0 0.4 0 0.5 0 0 0 0
Other Current Assets 25.8 25.0 9.0 1.6 10.2 12.0 10.9 13.2 19.5 19.1 13.0 2.0 2.1 3.1 1.1 1.7 10.2 0.6 0.1 7.9 0.1 (0.2) 0.1 0 0 (276.1) 0
Total Current Assets 124.1 126.2 122.5 156.5 152.3 160.7 171.8 182.9 194.0 206.3 208.7 209.0 209.2 218.1 225.4 278.2 285.3 314.4 294.9 342.7 13.3 0.9 14.4 1.1 1.2 1.4 1.8
Non-Current Assets
Property, Plant & Equipment 44.3 39.6 41.8 42.1 41.2 39.8 53.4 43.2 28.0 26.4 26.6 26.1 26.5 19.7 19.2 8.3 3.3 2.6 2.8 2.2 2.4 0 2.5 0 0 0 0
Goodwill 88.6 88.2 84.6 44.3 42.0 41.0 43.0 39.6 39.8 40.4 39.2 39.8 39.9 39.4 31.9 13.3 13.3 13.3 13.3 0 0 0 0 0 0 0 0
Intangible Assets 46.3 47.5 49.8 13.6 13.5 13.7 14.0 13.7 19.5 20.5 41.6 43.9 45.4 46.4 48.5 22.7 23.7 12.6 24.4 0.9 1.0 0 0.5 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0.4 0.4 0.4 0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0 0.2 277.2 277.1 276.3 0
Other Non-Current Assets 24.3 24.0 36.4 1.5 1.5 1.4 0.9 0.9 1.4 1.4 1.0 1.0 1.0 1.4 1.3 1.4 0.9 0.2 0.2 0.1 1.5 276.9 0.1 0 0 0 275.2
Total Non-Current Assets 203.5 199.3 212.6 101.4 98.2 95.9 111.2 97.4 88.8 88.7 108.8 111.2 113.2 106.9 101.3 46.0 41.4 28.9 40.9 3.4 5.1 276.9 3.3 277.2 277.1 276.3 275.2
Total Assets 327.6 325.5 335.1 257.9 250.6 256.7 282.9 280.3 282.8 294.9 317.5 320.2 322.4 325.0 326.7 324.2 326.6 343.4 335.9 346.1 18.3 277.8 17.7 278.4 278.4 277.7 277.0
Current Liabilities
Account Payables 20.0 0 0 13.7 0 0 0 0 0 0 0 14.9 11.4 16.5 0 0 0 4.4 6.4 0 2.1 0 0.8 0 0.1 0 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 4.8 0 0 0 0 0 0.5 0 0 0.3 1.2 0 1.2 0 0 0.2 0.2
Deferred Revenue 0 0 0 0 8.0 6.7 6.7 9.3 8.0 6.8 6.8 0 0 0 6.0 8.5 6.3 4.7 0 5.3 0 0 0 0 0 0 0
Other Current Liabilities 0 19.1 27.2 9.1 10.5 12.8 16.0 16.9 10.8 23.9 18.8 10.0 7.8 6.7 11.6 7.6 9.0 5.3 6.0 5.0 4.4 0.4 4.0 0.1 0.0 0.1 0.1
Total Current Liabilities 20.9 19.8 27.9 26.3 21.9 22.7 27.2 30.3 23.2 35.5 30.4 29.3 23.2 26.6 20.2 18.5 15.8 9.5 12.8 10.6 8.1 0.4 6.3 0.5 0.5 0.4 0.4
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 19.6 0 0 0 0 0 0.5 0 0 0.1 0 0 0 0 0 0.2 0
Deferred Tax Liabilities 0.3 0.3 0.2 0 0.2 0.2 0.3 0.4 0.4 0.5 1.4 0 0 0 0.1 0.1 0.1 0.2 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 17.2 23.6 21.2 3.2 3.1 5.8 2.7 2.4 1.5 5.0 3.3 10.3 8.2 9.0 9.1 9.5 28.8 42.2 31.5 38.8 47.2 9.6 0 9.6 9.6 0 9.6
Total Non-Current Liabilities 20.9 26.6 24.2 8.5 8.9 12.0 22.3 20.7 22.9 25.1 24.3 30.1 29.0 23.9 23.7 13.4 29.4 42.6 31.7 38.9 0.2 9.6 0.3 9.6 9.6 0.2 9.6
Total Liabilities 41.9 46.4 52.1 34.8 30.8 34.7 49.4 50.9 46.2 60.6 54.6 59.4 52.2 50.5 44.0 31.9 45.2 52.2 44.5 49.5 8.3 10.0 6.6 10.1 10.1 272.7 10.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 225.0 262.8 0.0 263.3 263.3 0.0 262.0
Retained Earnings (143.4) (145.6) (136.7) (194.1) (190.4) (186.9) (177.1) (175.2) (164.0) (159.8) (125.8) (126.1) (113.9) (103.7) (88.3) (79.0) (87.4) (77.2) (76.4) (68.0) (39.5) 0.9 (37.1) 1.4 1.4 0.8 0.1
Accumulated Other Comprehensive Income 0 0 0 6.0 3.1 1.8 4.2 2.8 3.1 4.0 1.7 3.2 3.2 2.3 (2.3) (0.4) (1.9) (0.3) (0.9) 0 0 0 0 0 0 0 0
Total Stockholders' Equity 285.7 279.1 283 223.1 219.7 221.9 233.5 229.4 236.6 234.3 262.9 260.8 270.2 274.5 282.7 292.3 281.5 291.2 291.4 296.7 10.0 267.8 11.1 268.3 268.3 5.0 267.0
Total Liabilities & Equity 327.6 325.5 335.1 257.9 250.6 256.7 282.9 280.3 282.8 294.9 317.5 320.2 322.4 325.0 326.7 324.2 326.6 343.4 335.9 346.1 18.3 277.8 17.7 278.4 278.4 277.7 277.0
Debt Metrics
Total Debt 4.5 3.3 3.5 8.8 9.1 9.3 23.7 22.0 25.5 24.5 24.3 24.2 24.8 18.3 17.1 6.1 1.0 0.7 0.7 0.4 1.8 0 1.9 0 0 0.5 0.2
Net Debt (54.3) (27.7) (19.3) (49.9) (25.8) (9.1) 3.7 (4.3) (11.2) (3.3) (12.5) (13.1) (16.9) (23.0) (34.7) (180.4) (1.5) (6.3) (1.9) (29.6) (8.4) (0.8) (10.3) (1.0) (1.1) (0.8) (1.6)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q3 2021 Q4 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Operating Activities
Net Income 2.4 (8.8) (9.7) (3.7) (3.5) (9.8) (2.0) (11.3) (4.2) (33.9) 0.3 (12.2) (10.2) (15.4) (9.2) 8.4 (11.0) (9.2) 0.8 (24.3) (1.1) (2.4) (0.7) (1.3) 0.6 0.7 0.1
Depreciation & Amortization 3.1 3.0 1.4 1.8 1.7 1.5 1.3 1.6 1.6 1.8 1.8 1.8 1.7 2.0 1.4 1.2 1.1 0.2 0.7 0.0 0.1 0.1 0.1 0.1 0 0 (82)
Stock-Based Compensation 0 6.6 0 5.3 4.2 0 5.4 0 0 9.2 0 2.8 3.2 0 0 1.8 2.1 0 2.9 0.0 0 1.3 0.2 0.1 0 0 0
Change in Working Capital (1.5) (11.9) 8.0 (6.0) 0.8 0.2 2.3 6.6 (12.2) (4.8) 3.7 (1.0) (9.5) 5.3 0.0 (6.3) 0.1 (0.5) 0.6 333.1 (0.1) 0.9 (0.5) 0.1 (0.3) 0.2 1.5
Other Non-Cash Items (0.3) 2.9 (32.2) (0.4) (3.5) 8.2 (0.6) 10.6 (0.7) 18.5 (3.9) 0.8 (1.9) 1.0 1.3 (16.8) (2.4) 7.3 (10.9) (308.8) 0.8 0 (0.1) 0.4 (0.5) (1.1) 80.4
Operating Cash Flow 3.6 (8.3) (31.8) (3.1) (0.2) 0.0 6.4 7.4 (15.6) (9.3) 2.0 (8.2) (16.9) (7.9) (6.5) (11.6) (10.1) (5.8) (6.0) (0.0) (0.4) (0.0) (0.9) (0.6) (0.2) (0.3) 1.5
Investing Activities
Capital Expenditure (5.5) (2.0) (3.1) (2.7) (3.1) (5.0) (9.9) (16.9) (1.1) (0.0) (0.7) (0.7) (0.6) (0.0) (0.1) (0.2) (0.4) (0.1) (0.2) (0.0) (0.1) (0.5) 0.0 (0.0) 0 0.0 0
Acquisitions (0.3) (2.9) (66.5) 0 0 0.0 0 0 0 0 0 0 0 0 (48.1) 0 0 (23.1) 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 (49.9) (12.2) (84.2) (0.5) (65.7) 0 (77.1) (0.0) (135.7) (0.0) (130.3) (107.5) (120.2) (0.2) (0.3) (5.6) 0 (0.3) 0 0 0 0 0 0 0
Sales/Maturities of Investments 30.5 23.2 121.9 43.5 107.8 9.5 65.2 0 102.7 0 133.3 4.5 147.2 108 39.7 197.0 11.7 11.3 17.2 0 0 0 0 0 0 0 0
Other Investing Activities 0 (0.2) 0 (0.4) (0.5) 0 (2.8) 0 0 0.1 0 0 0 0 0 196.8 0 0 (12.4) (0.0) 0 (0.5) 0 0 0 0 1.8
Investing Cash Flow 24.7 18.3 2.4 28.7 20.4 4.0 (12.6) (16.9) 24.6 0.1 (3.0) 3.8 16.3 0.5 (128.7) 196.6 11.0 (17.4) 4.6 (0.3) (0.1) (0.5) 0.0 (0.0) 0 0 1.8
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2)
Stock Repurchased 0 0 0 0 0 0 0 (0.2) 0 (0.0) 0 0 0 0 0 (1.0) 0 0 0 0 0 0 0 0 0 0 (1.8)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.6) (1.8) (7.3) (1.2) (4.3) (5.7) (0.7) (1.2) 0.1 0.0 (0.0) (0.0) (0.0) (1.2) (0.2) 0.1 0.0 (0.1) (3.1) 0.3 (1.8) (1.4) 0.0 1.2 0 0 1.8
Financing Cash Flow (0.5) (1.7) (7.2) (1.1) (4.2) (5.6) (0.7) (0.2) 0.1 (0.0) 0.0 (0.0) (0.0) (1.2) 0.0 (0.9) 0.0 0.2 (3.0) 0.3 (1.8) (1.4) 0.0 1.2 0 (0.3) 0
Cash Position
Net Change in Cash 27.8 8.2 (37.3) 24.6 16.0 (1.8) (7.0) (9.7) 9.0 (9.3) (1.1) (4.4) (0.6) (8.6) (135.3) 184.1 1.0 (23.1) (4.4) (0.8) (0.4) (1.9) (0.9) 0.6 (0.2) (0.5) 3.3
Cash at Beginning 31.2 23.0 60.3 35.7 19.6 21.4 28.4 38.1 29.0 38.3 39.4 43.8 44.4 53.0 188.2 4.2 3.2 30.6 7.6 0.8 0.8 12.3 13.2 12.6 1.3 1.8 (1.5)
Cash at End 59.0 31.2 23.0 60.3 35.7 19.6 21.4 28.4 38.1 29.0 38.3 39.4 43.8 44.4 53.0 188.2 4.2 7.6 3.2 0.0 0.5 10.3 12.3 13.2 1.1 1.3 1.8
Free Cash Flow (1.9) (10.3) (35.0) (5.8) (3.4) (5.0) (3.6) (9.5) (16.7) (9.3) 1.3 (8.9) (17.5) (8.0) (6.6) (11.8) (10.5) (5.9) (6.2) (0.0) (0.4) (0.5) (0.9) (0.6) (0.2) (0.3) 1.5
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q3 2021 Q4 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Income Statement
Revenue 67.4 66.8 49.3 70.8 54.3 54.4 74.9 67.9 51.5 47.5 71.4 61.0 45.3 38.1 45.7 35.6 26.6 20.3 24.6 13.0 0 8.0 8.3 3.4 0 5.2 0
Gross Profit 14.1 11.7 11.6 17.7 12.0 12.6 19.8 16.4 10.1 9.0 15.6 10.4 7.2 5.0 9.3 5.1 2.9 4.5 4.0 3.0 0 1.6 1.6 0.6 0 (0.5) (0.0)
Operating Income (3.0) (6.4) (5.6) (5.0) (7.6) (8.4) (3.5) (12.1) (9.9) (35.6) (7.4) (12.2) (12.8) (19.7) (10.4) (9.7) (13.7) (9.7) (10.5) (7.8) (0.2) (2.4) (0.7) (1.5) (0.1) (4.8) 0.1
Net Income 2.2 (8.8) 57.4 (3.7) (3.5) (9.8) (2.0) (11.3) (4.2) (33.9) 0.3 (12.2) (10.2) (15.4) (9.2) 8.1 (10.7) (9.2) 0.8 (24.3) (1.1) (2.4) (0.7) (1.3) 0.6 (4.7) 0.1
EPS (Diluted) 0.03 -0.11 -0.04 -0.05 -0.04 -0.12 -0.03 -0.15 -0.06 -0.45 0.00 -0.17 -0.14 -0.22 -0.13 0.12 -0.15 -0.13 0.01 -0.33 -0.06 -0.06 -0.01 -0.00 0.07 0.02
Balance Sheet
Cash & Equivalents 58.7 31.0 22.8 58.8 34.8 18.4 20.0 26.3 36.8 27.9 36.8 37.3 41.7 41.3 51.8 186.6 2.5 7.0 2.6 30.0 10.2 0.8 12.2 1.0 1.1 1.3 1.8
Total Assets 327.6 325.5 335.1 257.9 250.6 256.7 282.9 280.3 282.8 294.9 317.5 320.2 322.4 325.0 326.7 324.2 326.6 343.4 335.9 346.1 18.3 277.8 17.7 278.4 278.4 277.7 277.0
Total Debt 4.5 3.3 3.5 8.8 9.1 9.3 23.7 22.0 25.5 24.5 24.3 24.2 24.8 18.3 17.1 6.1 1.0 0.7 0.7 0.4 1.8 0 1.9 0 0 0.5 0.2
Stockholders' Equity 285.7 279.1 283 223.1 219.7 221.9 233.5 229.4 236.6 234.3 262.9 260.8 270.2 274.5 282.7 292.3 281.5 291.2 291.4 296.7 10.0 267.8 11.1 268.3 268.3 5.0 267.0
Cash Flow
Operating Cash Flow 3.6 (8.3) (31.8) (3.1) (0.2) 0.0 6.4 7.4 (15.6) (9.3) 2.0 (8.2) (16.9) (7.9) (6.5) (11.6) (10.1) (5.8) (6.0) (0.0) (0.4) (0.0) (0.9) (0.6) (0.2) (0.3) 1.5
Capital Expenditure (5.5) (2.0) (3.1) (2.7) (3.1) (5.0) (9.9) (16.9) (1.1) (0.0) (0.7) (0.7) (0.6) (0.0) (0.1) (0.2) (0.4) (0.1) (0.2) (0.0) (0.1) (0.5) 0.0 (0.0) 0 0.0 0
Free Cash Flow (1.9) (10.3) (35.0) (5.8) (3.4) (5.0) (3.6) (9.5) (16.7) (9.3) 1.3 (8.9) (17.5) (8.0) (6.6) (11.8) (10.5) (5.9) (6.2) (0.0) (0.4) (0.5) (0.9) (0.6) (0.2) (0.3) 1.5